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ABSTRACT Fluorescence Recovery After Photobleaching (FRAP) has been used extensively in the study of transport and
binding in biological media in vitro. The present study adapts and further develops FRAP so that it may be utilized for the in
vivo quantification of binding parameters. The technique is validated in vitro by measuring mass transport and binding
parameters for the Concanavalin A/Mannose binding system (a diffusion-limited system). The pseudo-equilibrium constant
(the product of the equilibrium constant and the total concentration of binding sites) for this system was determined to be
26 ± 15 which compares favorably with literature values ranging between 16 and 32. The applicability of this technique to
measure parameters for monoclonal antibody/antigen interactions in a thin tissue preparation such as the rabbit ear
chamber tissue preparation is also examined. Unlike other methods for measuring binding parameters, this is the only
technique which has the potential to measure parameters relevant to antibody delivery in vivo. The proposed technique is
noninvasive and does not require a priori knowledge of, independent measurement of, or variation in the concentration of
binding sites or total concentration of binding species.
INTRODUCTION
Monoclonal antibodies and other novel products of ge-
netic engineering have not realized their promise in the
treatment of solid tumors to date due to their poor
delivery to tumors (1). The delivery and distribution of
any agent in a tissue is governed by mass transport and
binding parameters. While measurements of mass trans-
port parameters have been made in vivo, there are no in
vivo measurements of binding parameters to date. Bind-
ing parameters measured in single cells (2), or multicellu-
lar spheroids (3) grown in vitro, while useful, may not be
representative of the in vivo situation. The use of Fluores-
cence Recovery After Photobleaching in conjugation with
the rabbit ear chamber (4, 5) or similar tissue preparation
offers the ability, for the first time, to quantify mass
transport and binding parameters noninvasively in nor-
mal and tumor tissues in vivo. This technique has the
potential to provide clinically relevant parameters which
may be used to predict monoclonal antibody distribution
in vivo.
To date, photobleaching methods have been developed
to study the lateral diffusion and binding of membrane
proteins in vitro. Using Total Internal Reflection Micros-
copy and Fluorescence Photobleaching Recovery (TIR/
FPR) residence times of bovine serum albumin on fused
silica (6), binding parameters for IgG and insulin on
albumin-coated silica (7) and binding parameters for
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epidermal growth factor on erythrocyte ghost membranes
(8) have been reported. While quite successful in in vitro
applications, these techniques are designed for the study
of two-dimensional surface kinetics and therefore have
not been applied to the task of measuring diffusion and
binding in an in vivo tissue preparation.
Various models of binding have been proposed to
measure parameters during photobleaching or concentra-
tion jump experiments, yet none are easily applied to in
vivo experiments. Elson and Reidler (9) propose a model
that may be used for diffusion-limited systems. They
extract the equilibrium constant by measuring the effec-
tive diffusion coefficient as a function of the concentration
of binding sites. This is impractical in vivo where not all
reactions are diffusion limited. The paper's suggestion
that the length scale of the photobleach could be in-
creased to make any system diffusion limited is impracti-
cal in vivo where the length scale of the bleach is limited
by the proximity of blood vessels which would contribute
significant error if they were to lay in the photobleached
area. Furthermore, in vivo the concentration of sites may
not be known a priori, and only rarely can the concentra-
tion of sites be modified. Koppel (10) presents a method to
obtain binding kinetics using periodic pattern photobleach-
ing. While this method is not restricted to the diffusion or
reaction limits, one must vary the periodicity of the
pattern to achieve closure. This method has not been
applied in vivo to date due to the difficulty in obtaining
periodic pattern photobleaches in an in vivo system.
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Fluorescence Recovery After Photobleaching (FRAP)
using Gaussian point-wise video digitization (GPD) was
proposed by Chary and Jain ( 11) as a means of measuring
convective velocity fields without a priori knowledge of
the direction of flow. This technique has been calibrated
in vitro (12) and has been used in vivo to quantify
diffusion coefficients of serum-soluble proteins and convec-
tive velocity fields in normal and neoplastic tissue (5)
through the use of a rabbit ear chamber (4). In FRAP
with GPD, a Gaussian profile is photobleached onto the
region of interest. Rather than using a photodiode which
detects light from the entire image, the image is point-
wise digitized to obtain the fluorescence intensity at each
picture element (pixel) in the region. The intensity profile
as a function of radial position is fit to a Gaussian function
at each time point to accurately track the center point
intensity and position of the bleach. Through minimiza-
tion of the sum of squares error between the predicted and
measured center point intensity, mass transport parame-
ters can be obtained. In this paper, we develop models for
the in vivo application of GPD in measuring mass
transport and binding parameters, assess the accuracy of
this technique in vitro, and discuss its possible in vivo
applications. FRAP in conjunction with a thin transpar-
ent tissue preparation seems to have the potential to allow
clinically relevant determination of antibody/antigen ki-
netics.
= DV'Cl, k,C,jAg + kI,C2i
=C2i= k, C,iAg - k_IC2i.
(2)
(3)
These equations must be written for both fluorescently
active (i = a) and bleached (i = b) macromolecules.
C,i = concentration of mobile macromolecule.
C2j = concentration of immobile (bound) macromolecule.
Ag = concentration of vacant binding sites.
The geometry of the system is cylindrical with depen-
dence only in the radial direction (r)' so that:
V2C=l1 ac .
r Or Or)
The initial condition is imposed by the Gaussian intensity
profile of the laser beam2 and by the facts that the bound
and unbound components are in equilibrium and are
bleached to the same extent:
CTa(r, t = 0) = CTB + (CTU - CTB) [1 - exp
k, C2a C2a
k-I CiaAg Cla(Ago - C2a - C2b)
k, C2b C2b
k I Clb Ag Cl,b(Ago - C2a - C2b)
(5)
(6)
(7)
(4)
THEORETICAL STUDY
Model development
One of the simplest models of binding is the case of
reversible binding to one type of site. Such would be the
case for a monoclonal antibody or Concanavalin A (Con
A) molecule which does not exhibit nonspecific binding or
entrapment. This model has proven to be effective in both
monoclonal antibody and Con A studies (1 3, 14) and is an
excellent approximation if the molecule does bind to more
than one type of site if secondary sites form unstable
complexes or are sparse. The feasibility and sensitivity of
using FRAP with GPD to quantify mass transport and
binding parameters both in vivo and in vitro are assessed
by solving the diffusion equation for this binding system.
The diffusion equation with reversible binding to one
type of site assuming uniform distribution of binding
sites, an immobile bound complex, and no convective field
is:
ki
C];i+ Ag-;:~C2;i
CTi = total concentration of macromolecule = C,l + C2i (CTa
is measured).
CTU = total concentration of fluorescently active macromole-
cule well beyond the bleached region.
CTB = total concentration of fluorescently active macromole-
cules at r = 0 and t = 0.
Ro= radius of the bleached spot at t = 0 such that
CT(RO, t = 0) = (1 - l/e2)CTU, i.e., the Gaussian
radius of the bleach.
Ago = total concentration of binding sites.
CTU, CTB, and Ro are obtained by fitting the data to a
Gaussian function. The initial conditions and definition of
CTA represent four nonlinear algebraic equations for the
'The characteristics of our bleaching beam have been described previ-
ously (12). The diameter of the beam (d) entering the objective is 494
,um and the focal length (f) of our 20x objective is 8 mm. Using the
formula (48):
DOF=-
yields a depth of focus (DOF) of 325 Am, several times the depth of our
preparation.
2Eq. 5 is valid only for "shallow" bleaches (11). Axelrod (49) presents
formulations incorporating arbitrary extents of photobleaching.
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initial concentrations of the four components. These
equations were solved numerically.
The boundary conditions are:
VC1j = VC2j = O at r =O and as r oo. (8)
The equations were made dimensionless by introducing
the following groups:
OTa = O1a + 02a CTa
CTU CTB
1a-= Cia C2a CTB (9)
CTU - CTB 02a CTU - CTB
CTb
0Tb = 1 0Ta = 01b + 02b = CTU CTU-CTB
OlbCib
_2b C2b ( 0)CTU - CTB CTU TB
r Dt R2k, Ago
Z =- T= j-j Da
Ro R 2 D
CTB kjAgO CTB
Ago k
=
CTU - CTB
As a result, the equations describing the fluorescence
recovery after photobleaching become:
aOIa 1 / aOla\
9-r za z /z
DaOa[1 (2 + + 02a + (12)
9O2a D [(O 2B'a a+ (13)
D OlaLIya/ (13
0091b 1 9 90 b\
ar zOz az/
-D lb I a + I) (14)
-02b= D 02a + 02b ()] -Jb} (15)
where 0Ta iS the dimensionless total concentration of
fluorescently active macromolecule (reported as 0 on the
accompanying figures) and Oli and 02i represent the mobile
and immobile components, respectively. Z is the dimen-
sionless radial coordinate and r the dimensionless time.
Da, a, /3, and y represent the Damkoehler number (the
system is diffusion limited when Da >> 1 and reaction
limited when Da << 1), extent of saturation, pseudo-
equilibrium constant, and depth of bleach. The four
coupled nonlinear partial differential equations were solved
numerically.
Assessment of numerical solution
Analytical solutions to the above non-linear equations
exist when (a) no binding occurs (5) or (b) binding is
instantaneous (Da >> 1 and a << 1). In an instantaneous
reaction (diffusion limited), the bleached and active
components are always in equilibrium. Crank (15) demon-
strates that for such a case the solution is identical to that
of the nonbinding case except that the diffusion coefficient
is reduced by a factor of 1 + /3. Thus the analytical
solutions for the dimensionless center point concentration
as a function of dimensionless time are:
8r
OTa(Z = ) + 8T
8
and OTa(Z = 0 T) = 8
1+ + r
(16)
for no binding and instantaneous binding, respectively.
Comparison of the numerical to the analytical solution for
the above two cases shows excellent agreement between
the solutions (data not shown).
Sensitivity of gaussian point-wise
digitization
As discussed previously, the GPD technique monitors the
fluorescence intensity at the center of the bleach as a
function of time to obtain the mass transport and reaction
parameters. Previous experiments (5) have measured
diffusion coefficients in vivo using this technique with an
accuracy of at least ± 50%. For the presence of binding to
be detected by FRAP in vivo, binding must slow the
recovery to an extent greater than a 50% reduction in the
diffusion coefficient. FRAP is feasible for a binding
system if the recovery curve does not intersect the shaded
area of Figs. 1, 3, 6, 10 a, and 10 b which represents the
error associated in measuring D for the nonbinding case.
In measuring the mass transport parameters for a given
interaction, one could possibly control the parameters
CTU, D, RO, Ago, and y. As seen in Fig. 1, when CTU is
greater than Ago, the fluorescence recovery curve is no
different from that of diffusion alone. This is due to the
fact that the binding sites are saturated and mobile
species are able to diffuse unhindered by the effects of
binding. FRAP will not be able to obtain meaningful
binding parameters in this case due to the fact that a
model of diffusion only would fit the data with equal
ability as a binding model. When CTU is less than Ago,
recovery occurs mainly through the dissociation of the
bound complex because there are very few free molecules.
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FIGURE 1 Dimensionless concentration of fluorescently active macro-
molecule at the center point as a function of dimensionless time and
concentration of binding species. The shaded region represents the area
in which recovery is not significantly different from that of diffusion
alone and binding parameters cannot be obtained. Parameters used for
this simulation are: Da = 1,646, # = 15, y = 3, and Ago = 6 x 10-4 M.
FRAP will discern the recovery with binding from that of diffusion alone
when the concentration of binding species is less than the concentration
of binding sites.
In this case, recovery is significantly different from that of
diffusion alone and application of FRAP/GPD should
yield the parameter A if the system is instantaneous, or the
parameters kl, kl, Ago, and D (through numerical solu-
tion of Eqs. 12-15) if the binding regime is noninstanta-
neous (reaction limited). When Eqs. 12-15 are rear-
ranged to obtain 0 as a function of real time rather than
dimensionless time, Ro and D do not appear in any of the
binding terms. Thus, while decreasing D or increasing Ro
will cause the recovery to occur more slowly, it will not
dissociate the recovery with binding from that of diffusion
alone. Altering the extent of the bleach y while keeping
CTU constant, accomplished experimentally by altering
the laser exposure time, does not affect the recovery
because it does not alter the kinetics of the interaction.
EXPERIMENTAL STUDY
One of the most widely studied biological binding interac-
tion is that of the lectin Con A with gluco and manno
sugar residues (14, 16-18). The present study measures
the mass transport and reaction parameters for Con A's
interaction with Mannose in vitro using FRAP with GPD
and compares these values to those previously published
using other measurement techniques to assess the accu-
racy of the proposed technique. This study demonstrates
that FRAP/GPD is capable of reproducing mass trans-
port and reaction parameters for Concanavalin A and
shows promise as a tool for quantifying these parameters
for monoclonal antibody/antigen interactions for the first
time in vivo.
Samples
Fluorescein Isothiocyanate labeled succinyl-Concana-
valin A (FITC-suc-Con A) was obtained from Sigma
Chemical Co. (Product #L-9385, Lot #118F8055; St.
Louis, MO). Succinylation ensures that the species exists
as a dimer of molecular weight 56,000 g/mol (19). The
dye to protein ratio of the lot used was 1.3. Experiments to
measure the free diffusion coefficient of FITC-suc-Con A
prepared a 1 x 10-5 M solution of the species in 0.5 M
NaCl. All samples were drawn by capillary action into a
50-,Mm thick glass capillary slide (#W5005; Vitro Dynam-
ics, Rockaway, NJ) for observation conducted at 23 ±
20C. Experiments to measure the diffusion coefficient of
Con A with binding to Mannose required that the binding
sites be uniformly distributed and immobilized. To achieve
this, Mannose covalently bound to sepharose beads which
themselves are inert to Con A (Product #M 6400, Lot #67
F-9591; Sigma Chemical Co.) was homogenized by
continuous stirring for 72 h. Sigma Chemical Co. esti-
mates the concentration of immobilized Mannose on
product #M 6400 to be between 6.5 x 10-4 and 1.3 x
10-3 M. These beads are supplied in 0.5 M NaCl. In
preparing the sample for the binding experiments, homog-
enized Mannose-sepharose and 3.8 x 10-6 M FITC-suc-
Con A in 0.5 M NaCl were mixed 1:1 and drawn into the
50-,Mm capillary slide for observation. Two types of
samples were used to measure the diffusion coefficient of
FITC-suc-Con A in a sepharose matrix with no binding.
The first sample was a 1:1 mixture of 3.8 x 10-6 M
FITC-suc-Con A and homogenized sepharose beads that
did not contain Mannose (Product #CL 4B200 Lot #58
F-0376, Sigma Chemical Co.). The second sample con-
sisted of a saturating concentration of Con A (4 x 10-3
M) in the same Mannose-sepharose used in the binding
experiments. Saturating conditions ensured that the effect
of binding was negligible (Fig. 1) and the use of the
Mannose-sepharose matrix ensured equal tortuosities in
binding and nonbinding preparations. There was no
statistical difference (p = 0.14) between the two nonbind-
ing samples.
Equipment
The equipment, experimental procedure, and data analy-
sis technique used in this study are nearly identical to
those described in reference (12). Briefly, the capillary
slide was trans-illuminated at 480 nm by a mercury vapor
lamp (model HBO 100W; Zeiss, Morgan Instruments,
Cincinnati, OH). Light passed through a heat reflector
(model Califax; Carl Zeiss, Inc., Thornwood, NY), heat
absorber (model KG-1; Carl Zeiss, Inc.), FITC exciter,
and red absorber filters (models 46-79-79 and 46-78-85;
Carl Zeiss, Inc.). The microscope was focused on the
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sample using a 20 x objective (model F-LD 20/0.25,
46-06-05; Carl Zeiss, Inc.). Light emitted from the
sample was passed through a barrier filter (model 46-78-
33; Carl Zeiss, Inc.) and the 1.25 x lens in a Zeiss Optovar
(model 47-16-45; Carl Zeiss, Inc.) installed in the micro-
scope barrel. The image was monitored using a Silicon
Intensified Target camera (model 4400; Cohu, Inc., San
Diego, CA) operated in a range where measured intensity
was linear with fluorophore concentration (20), and the
signal sent to an image analysis system (DT-IRIS; Data
Translation, Marlboro, MA) housed in an IBM PC-AT
allowing on-line digital analysis of the video image.
A 5-W argon ion laser (488 nm) (model 2000-5;
Spectra Physics, Mountain View, CA) was used to
photobleach the sample. The laser beam was directed
through a spatial filter (model 91 OB; Newport Corpora-
tion, Fountain Valley, CA) and focused using a 5 x
microscope objective (model M-5X, Newport Corpora-
tion). The beam accessed the sample via the epi-
illumination port where it was attenuated using neutral
density filters (models 46-78-40, -41, -42; Carl Zeiss,
Inc.). Two shutters (Uniblitz Electronic, Vincent Assoc.,
Rochester, NY) were used to control the bleaching time
and light reaching the camera. The shutters were electron-
ically controlled, allowing a bleach time as low as 10 ms.
RESULTS
Because the Damkoehler number for the binding of Con
A to Mannose is much greater than unity (17, 22) the
instantaneous binding model (Eq. 16) was used for this in
vitro calibration. Assessment of accuracy was based on
the comparison of the pseudo-equilibrium constant ,B
obtained by our technique to the literature value of #
obtained by other methods. To establish a baseline, the
free diffusion coefficient (Do) of FITC-suc-Con A was
measured. The diffusion coefficient of this same species in
a nonbinding system (D) is <Do due to the tortuosity of
the sepharose matrix. The diffusion coefficient in a bind-
ing system (Deff) is reduced due to both tortuosity and the
immobilization reaction. $ was obtained by rearranging
Eq. 16 to yield:
D
Deff
1. (17)
Gaussian fits of the fluorescence intensity as functions of
radial position and time as well as comparison between
measured and predicted center point concentration as a
function of time for nonbinding and binding experiments
are shown in Fig. 2. Results of the in vitro calibration are
shown in Table 1.
Experimental procedure
After background image acquisition and storage, a region
in the sample was photobleached for 0.01-0.2 s (depend-
ing upon the preparation). Upon closing the laser shutter,
the camera shutter was opened to allow imaging of the
sample. As described in reference 12, five frames were
averaged at every time point to ensure an acceptable
signal-to-noise ratio. The process of acquiring and storing
the frames took - 1.4 s for each time point. The data from
the monitoring region (90 x 70 pixels or less) was stored
in the system buffers. This process was continued for up to
15 s after the bleach. After the background image was
subtracted, the data were stored for subsequent analysis.
Analysis procedure
Data analysis was conducted on a Sun Microsystems, Inc.
(Mountain View, CA) 3/260 workstation. A gaussian
profile was fit to the intensity data at each time point
using nonlinear parameter estimation (21). This fitting
enabled accurate tracking of the center point fluorescence
intensity. Mass transport and binding parameters were
obtained by minimizing the sum of squares error between
the model (Eq. 16) and the measured center point
concentrations.
DISCUSSION
FRAP/GPD is capable of accurately and noninvasively
quantifying the pertinent transport and binding parame-
ters for a given binding regime from a single photobleach,
without previous knowledge of system parameters. This
technique will allow for the first quantification of binding
parameters in vivo. The one site model assumes a uniform
distribution of binding sites and neglects secondary bind-
ing, thermal effects, and convection. The implications of
these assumptions to both in vitro and in vivo experiments
are discussed and the problem of paucity of data in
determining the parameters of interest is addressed.
IN VITRO APPLICATIONS
Experimental calibration
The free diffusion coefficient measured for dimeric Con A
agrees favorably with that predicted by the Stokes-
Einstein equation for a prolate ellipsoid (23) with succinyl-
Con A's dimensions (24) and is slightly higher than that
measured for trimeric Con A (molecular weight 84,000)
(22) as expected. Sigma Chemical Co. estimates the
concentration of Mannose on product M-6400 to be
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TABLE 1
Do 7.4 ± 1.6 x 10-7 cm2/s (n = 60)
D 3.8 ± 0.81 x 10-7 cm2/s (n = 39)
0.14 ± 0.05 x 10 ' cm2/s (n = 40)
Measured Literature
26 ± 15 16-32
Do = free diffusion coefficient, D = diffusion coefficient in nonbinding
system, D,ff = effective diffusion coefficient in sepharose matrix with
binding to Mannose, # = pseudo-equilibrium constant for the binding
interaction. Values are reported as mean ± SD. Parameters measured
by FRAP are in good agreement with literature values.
t=32.8s
t = 9.7 s
t = 0.5s
10 20 30
Radius (pm)
20
Time (s)
FIGURE 2 Fluorescence intensity as a function of radial position was fit
to a gaussian function at each time point to accurately track the center
point concentration. The data were fit to a gaussian function using each
of the 6,300 pixel values in the monitoring region. Data points have been
condensed in Fig. 2, a and b for the sake of clarity. Fig. 2, a and b are
representative curves from nonbinding and binding bleaches, respec-
tively. The center point intensity as a function of time is used to
determine the diffusion coefficient as shown in Fig. 2 c . The standard
deviations of the center point concentrations are <0.007 and cannot be
seen. These bleaches yielded diffusion coefficients of 4.18 ± 0.26 x 10-7
cm2/s and 0.18 ± 0.02 x 10-7 cm2/s for nonbinding and binding
systems, respectively.
between 6.5 x 1O-4 and 1.3 x 1O-3 M. Farina and
Wilkins (17) report the equilibrium constant for the Con
A/Mannose interaction to be 2.5 x 104 M-1, yielding a
value of ,B between 16 and 32. Using FRAP/GPD, ,B was
determined to be 26 ± 15, in good agreement with
Farina's value. The large standard deviation associated in
reporting : is due to the fact that because ,B is obtained by
taking the ratio of two variables each having associated
error, the relative error in ,B is the sum of the relative
errors ofD and Deff.
Model assumptions
Uniform distribution of binding sites
The one site model assumes than the binding sites are
uniformly distributed throughout the region of interest. In
the Con A/Mannose binding experiments, 60-140-,um
diam sepharose beads were homogenized by continuous
stirring for 72 h resulting in pieces that were <5 ,um in
largest dimension. Due to the fact that any inhomogeneity
is averaged vertically over the 50-,gm thickness of the
capillary tube and horizontally over the -45-,um radius of
the photobleach, the continuum hypothesis may be used.
If inhomogeneity were a problem, it would be evidenced
in a bimodal distribution of diffusion coefficients. Diffu-
sion coefficients would be low when the bleached region
was centered on a piece of bead having a high concentra-
tion of binding sites and high when the bleach was
centered on a void region. This bimodal distribution was
not seen, supporting the homogeneous distribution assump-
tion.
Secondary binding
The one site model assumes that the mobile macromole-
cule binds to a single type of site and that nonspecific
binding or entrapment does not take place. While second-
ary interaction is difficult to quantify, a two site model is
developed to demonstrate the relative importance of
secondary interactions in the binding systems discussed in
this paper. Secondary binding is taken into account by
solving the diffusion equation with reversible binding to
two competitive sites, a parallel reaction scheme. This two
site model, developed in Appendix A, demonstrates that
secondary interaction may be neglected if the affinity for
the secondary site is weak or if the distribution of such
sites is sparse. Appendix A demonstrates that the effect of
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a racemic mixture of Mannose in the Concanavalin
A/Mannose experiments is negligible.
Temperature increases
Mass transport and reaction parameters are temperature
dependent. Local heating of the sample due to laser
absorption by the sample and the fluorophore could alter
these parameters. Laser beam characteristics and ther-
mal effects for our system have been reviewed in reference
12. Welch et al. (25) proposed a model to account for
heating due to absorption by the sample. As demonstrated
in reference 12, sample absorption will lead to <0.040C
temperature rise in vitro (0.2 s bleaches). Simon et al.
(26) calculated the temperature rise due to fluorophore
absorption. Based upon these calculations, we expect less
than a 1OC rise for the concentration of fluorophore in
vitro. Both of these calculations are conservative because
they assume that absorption is uniform with axial dis-
tance and neglect heat losses from the surface of the
sample. Using the Stokes-Einstein Equation (23) and
viscosities of water given in reference 27, a temperature
increase of 20C would increase the diffusion coefficient of
Con A in water by 5%, a negligible amount compared
with the standard deviation associated with measurement
of this parameter. Successive bleaches are conducted at 5
min intervals to allow for data storage. This is sufficient
time for the relaxation of any thermal gradient that does
result from laser heating.
IN VIVO APPLICABILITY
One cannot a priori predict whether the time scale for a
given binding interaction will be compatible with the time
scales required by the FRAP technique. The mathemati-
cal model of diffusion with reversible binding made
possible the assessment of the feasibility of using FRAP
to measure the mass transport and reaction parameters
for a given binding interaction. Using the one site model
and assuming that the parameters of Dower et al. are
correct, one sees in Fig. 3 that FRAP/GPD will be
capable of reproducing these parameters as long as the
concentration of antibody used in in vivo experiments can
be held below 1 x 10-7 M. The requirement of low
concentration of antibody could pose a problem because
the binding species is the source of the fluorescence signal.
As the concentration of fluorescent material (binding
species) is decreased, the medium becomes increasingly
more difficult to bleach and the signal-to-noise ratio in.
measuring the fluorescence intensity of the region is
greatly decreased. The in vitro calibration using Con A
did not present these problems due to a high concentration
of Mannose in the sepharose matrix. The tumor, however,
0.6
0
CTU=2.8X107M
***+ + + + + + CTU = 1A X 10-7 mV
O00000CTU=6.9x1O8M
0.0
0.0 0.1 0.2 03 OA 0.5 0.6 0.7 0.8 0.9 1.0
IT
FIGURE 3 Recovery curves for a binding system as a function of the
total concentration of binding species. The shaded region represents the
area in which recovery is not significantly different from that of diffusion
alone and binding parameters cannot be obtained. Kinetic parameters
and concentration of binding sites are taken from Dower et al. (2);
yielding Da = 0.156 and , = 15.76. Assuming Dower's parameters are
correct, FRAP/GPD should be capable of reproducing them in vivo if
the concentration of antibody in the interstitial space is kept below 1 x
10-7 M.
may have a very low concentration of binding sites which
would require the use of a concentration of binding
species lower than the 1 x 10-6 M FITC which has been
found to be optimal in our FRAP studies. For this
technique to have broad applicability, a more sensitive
camera (e.g., ISIT or ICCD) or a fluorescent label with a
more intense emission (e.g., BODIPY [28]) may have to
be used.
The literature that exists representing in vitro studies of
monoclonal antibody binding parameters (2, 29-37) dem-
onstrate that due to the low concentration of binding sites,
it may not always be possible to use the instantaneous
binding model. In noninstantaneous regimes, Eqs. 12-15
must be repetitively solved numerically in any parameters
estimation schemes to predict kl, k1, Ago, and D. The
task of parameter estimation and validation of the FRAP
technique is the topic of ongoing research. Regardless of
the binding model used, FRAP is capable of providing the
pertinent binding parameters. Although the instanta-
neous model provides only Doff from a single photobleach
(or a if D is known) Baxter and Jain (manuscript
submitted for publication) have recently established that
if the interaction is instantaneous Deff is all that is needed
to predict macromolecular transport in vivo.
The models discussed thus far have assumed that no
convective velocity fields exist in the region being moni-
tored. Obviously this is not the case in vivo where the
average interstitial fluid velocity (v) in the rabbit ear
chamber preparation has been measured to be -0.5 ,um/s
(5). Taking the diffusion coefficient for IgG (a molecule of
interest for cancer detection and therapy) measured by
FRAP to be 2.3 x 10-7 cm2/s (unpublished observations)
and Ro to be 4 x 10-3 cm, this translates to a Peclet
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number (Pe = vRO/D) of 0.87. When Pe >> 1 convection
is the dominant mode of transport, whereas when Pe << 1
diffusion is the dominant mode. By failing to account for
the movement of the mobile macromolecule, the fluores-
cent intensity at the initial center point is overestimated
(Fig. 4) leading to an overestimation of the diffusion
coefficient. The effect of a convective field is most pro-
nounced when no binding takes place because this repre-
sents the maximum flux of macromolecules into and out
of the bleached region. Error analysis for the nonbinding
case thus represents a worst case scenario because errors
associated with convection in binding systems will be
much smaller.
The dimensionless fluorescence intensity without bind-
ing as a function of dimensionless time and position is
(12):
O(Z, T) = 1 -(1 8)ex((I + 8) (18)
Due to convection (plug flow), the position of the curve is
displaced with time by an amount vt. The dimensionless
displacement in time is Per. Accounting for the displace-
ment of the curve due to convection, the dimensionless
intensity at the initial center point of the Gaussian profile
as a function of dimensionless time and Peclet number
becomes:
0 (z = O, T, Pe) = 1I I T exp( I + 8T (I9
If convection is neglected (as done in this paper) the
center point is expected to remain stationary and to have a
dimensionless fluorescent intensity governed by Eq. 16.
Thus, by neglecting the convective field the center point
intensity is overestimated by a factor of:
- 2(Per)2
I - exp 1 8r
% difference = 8r x 100%. (20)
One sees in Fig. 5 that for the expected Peclet number
and monitoring time, the error in measuring the center
point intensity neglecting the plug flow convective field is
-2%. Even if the convective velocity were doubled, the
error in measuring the center point intensity would
be <10%. This overestimation of the center point intensi-
ties with time leads to an overestimation of the diffusion
coefficient. If data is generated using Eq. 19 with Ro =
4 x 10-3 cm and D = 2.3 x 10-7 cm2/s for 12 s and this
data is then fit to Eq. 16 to obtain the "measured"
diffusion coefficient, one finds that neglecting the convec-
tive field leads to an overestimation ofD by 2.6 and 11.3%
for Pe = 1 and 2, respectively. This error is clearly
insignificant compared with the -30% standard deviation
reported in measuring diffusion coefficients using GPD
both in vivo and in vitro (5, 12).
The effect of convection will be less pronounced for
binding systems. As demonstrated in Fig. 1, for FRAP/
GPD to obtain parameters, the system must not be
saturated. At this low concentration of binding species,
<40% of the macromolecule will be mobile and will
experience the moving profile seen in Fig. 4. Thus, for
binding systems the overestimation ofD (and subsequent
underestimation of f,) will be significantly less than the
already acceptable 2.6% calculated above.
Because tracking the center point location is not
required to obtain the parameters of interest, fitting the
profile to a gaussian function at each time point, as was
-1.5 -1.0 -0.5 0.0
z
0.5 1.0 1.5
0 l * I . l I . I . I
FIGURE 4 Overestimation of the center point fluorescence intensity
associated with the neglection of a plug flow convection field. By failing
to account for the plug flow convective field, here taken as Pe = 1 in the
-z direction, one slightly overestimates the fluorescent intensity at the
"center point" by measuring A, B, C, at r = 0, 0.25, and 0.5,
respectively instead of the true A, B', C'. This overestimation of the
fluorescent intensity will lead to an overestimation of the diffusion
coefficient.
Pe = 2
Pe = 1
Pe = 0.5
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
IT
FIGURE 5 Percent overestimation of the "center point" dimensionless
fluorescent concentration associated with neglecting the plug flow
convective field as a function of dimensionless time and Peclet number.
Note that for physiologically realistic Peclet numbers the percent error
is -2%.
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done in the Con A calibration experiments, is unneces-
sary. One could make use of more of the available data by
averaging the intensity over a small region centered about
the bleached spot. Development, sensitivity, and feasibil-
ity of this method are given in Appendix B.
As discussed previously, the one site model assumes a
uniform distribution of binding sites in the media through
which the antibody is diffusing. This may not be realistic
in all physiological situations. Chary and Jain (5) discuss
how the application of FRAP in vivo may measure the
diffusion coefficients of macromolecules in an "aqueous"
rather than a "gel" like phase. They use this argument to
describe why FRAP measures diffusion coefficients in
vivo which are closer to the diffusion coefficient of the
species in water than the lower in vivo diffusion coeffi-
cients measured using techniques (38) which monitor
transport on a much longer time scale. If this is indeed the
case, the binding sites must be in intimate contact with
the "aqueous" phase for FRAP to detect the slower
recovery due to binding in vivo. The uniformity of sites is
in relation to the radius of the photobleached region. Cell
surface antigens are confined to the surface of -15-lim
diam tumor cell, and not all the cells in the tumor mass
may express a given antigen (39-41). Although any
heterogeneity will be averaged over the 50-,um thickness
of the rabbit ear chamber tissue preparation and -90-uim
diam of the bleached region, confinement to the cell
surface as well as heterogeneous expression of the antigen
may necessitate a more intricate model for certain anti-
gens. The model presented in this paper best describes
high molecular weight tumor associated antigens which
are "shed" from the cell surface into the interstitial space
such as Ferritin (42) or carcinoembryonic antigen (43).
In vivo studies will first address the more simple mass
transport problems of these shed antigens.
Secondary or nonspecific binding is difficult to quantify
in vivo and one must report the effective reduction in
diffusional rate due to binding. While such parameters
may not represent the "true" kinetics of the monoclonal
antibody/antigen interaction, they are useful for predict-
ing monoclonal antibody distribution in vivo because they
intrinsically account for nonspecific interaction. The two
site model may be utilized to demonstrate the effects of
nonspecific interactions and to place bounds as to when
these interactions will alter the determination of primary
interaction parameters.
As in the in vitro experiments, thermal effects may also
be neglected in vivo. The temperature rise due to sample
and fluorophore absorption are both <10C for in vivo
experiments. Again these figures are overestimations
because the calculations do not account for convective
heat loss due to blood flow.
Paucity of data
The one site model in a noninstantaneous regime requires
the estimation of the four parameters D, kl, k_1, and Ago.
Our current data acquisition system is able to discern a
bleached spot for a system with no binding for only 12 s,
and in that time is able to acquire data for only eight time
points. Binding systems are discernable for a longer
period of time due to their decreased effective diffusivity,
but still may not yield enough data points to accurately
estimate the four unknown parameters. The problem
presented by the paucity of data may be overcome by
reducing the number of unknown parameters that need to
be estimated or by increasing the system's capability
allowing more data to be acquired. The number of
unknown parameters may be reduced by measuring the
diffusion coefficient for the macromolecule independent of
binding. This is most accurately accomplished by using an
antibody of the same class, molecular weight, and charge
as the monoclonal antibody under investigation which is
not reactive with binding sites in the tumor. In many
instances, the binding interaction will be instantaneous
(as in the Con A/Mannose system) and will require the
estimation of only the lumped binding parameter f,. In
most biological binding interactions, the key component
determining the magnitude of the Damkoehler number
(which determines if the interaction is instantaneous) will
be the concentration of binding sites. Work by Guadagni
et al. (44, 45) has demonstrated that for some tumor
associated antigens it is possible to dramatically increase
the concentration of binding sites through the administra-
tion of interferon. It may thus be possible using interferon
to both render an interaction instantaneous which was not
so before and simultaneously allow for the use of a higher
concentration of binding species. The capability of the
data acquisition system may be increased through im-
proved technology or alternative measurement tech-
niques. Improved data acquisition boards may triple the
rate of data acquisition thereby tripling the amount of
data. Improved objectives and more sensitive cameras
may be capable of discerning the bleached region for
longer periods of time, further increasing the amount of
available data. In this paper, the center point position and
concentration were determined by fitting the intensity
data to a gaussian function. This required the acquisition
of a large number of pixels at each time point and hence a
longer data acquisition time. As demonstrated earlier,
fitting to a gaussian profile and tracking the center point
position is unnecessary. One may "fix" the center point or
average the intensity over a small region with minimal
error associated in measuring the diffusion coefficient and
with fewer pixels acquired at each time point. This will
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dramatically increase the data acquisition rate, providing
adequate data for parameter estimation.
Through the methods developed in this paper, FRAP is
capable of accurately measuring the pertinent mass
transport and binding parameters from a single photo-
bleach. In conjunction with the rabbit ear chamber or
similar tissue preparation, this will allow the first quantifi-
cation of these parameters in vivo and will yield the most
clinically relevant parameters to date for use in improving
the delivery of therapeutic agents to their target tissue.
Unlike previous methods to measure these parameters,
this method is capable of being conducted in vivo, does not
intrinsically alter the system of interest, and does not
require a priori knowledge or variation of system parame-
ters.
Ola = CilaCTU - CTB
82a = C2aCTU - CTB
C3a - CTB
0a - CTU - CTB
OTB =1 - Ta - Olb + 02b + 03b - CTbCTU - CTB
01b = ClbCTU - CTB
02b =
C2b 9
= C3b
CTU - CTB 3b - CTU - CTB
r Dt CTB
z=- =- =Ro R2 ~CTU -CTEB
(A7)
R2k1xAgo
Da-= D
APPENDIX A
Two site model
Theoretical development of the two site binding model, like the one site
model, assumes a uniform distribution of binding sites, an immobile
bound complex, and no convective field. The diffusion equation with
reversible binding to two competing sites is:
Cl
+ Ag1 C2
k+C
k2
+ Ag2 i;: C3
k-2
Rok2(1 - x)Ago
Da2-
k2(1 - x)Ago
(532= k-2
CTB (
a' x)Ago.(All1)
The equations describing the fluorescent recovery after photobleaching
become:
9OIa 1I ( a ) [1 I + )J 2a
P- Dal ~O1all -al V(02a + 02bJJ
(Al)
Da2 (Ola a2 (3a + 3b) + I
O rz
ly 0
(A 1 2)
a0lC = DV2Cl - k1CliAg, + kIC2i
- k2C,jAg2 + k-2C3i
0C2, = k1CliAg1 - k C2i
9C3i= k2CI1Ag2- k 2C3i-
(A2)
(A3)
(A4)
These equations are written for fluorescently active (i = a) and bleached
(i = b) molecules. Ago is the total concentration of binding sites. xAgo is
the concentration of "primary" sites which lead to the C2j bound
complex, whereas (1 - x)Ago is the concentration of secondary sites
leading to C3j. The Laplacian operator and the initial condition on CTa
(CTa = Cla + C2a + C3a) are identical to those in the one site model.
The initial conditions for the individual components are defined by the
four equilibrium conditions that may be written in a similar fashion as
Eqs. 6 and 7. These equilibrium conditions as well as the initial condition
for CTa and the definition of CTb represent six nonlinear algebraic
equations for the six components and may be solved numerically. The
boundary conditions for the components are defined in a similar manner
as the one site model Eq. 8.
The differential equations were made dimensionless by introducing
the following groups:
OT. = Ol a + 0R2. + 03a = Ta CTB (AS)
CTU - CTB
a06b I az (6lb{ ab [ (82a + 022b)] } b)
Da2 (lb{1 - a2 [ (03a + 03b) + I (A) 3)
aT a l[ 8a+ 2) 0a)Da1 lb(aI [(a02a + 02b)J
0 (02b)\
= Dal l0b I1- al[ (02a + 02b)~
0103a
=Da2 (Oia fI a2
(03a + 03b) + I
d(3b (sf1 [i,b(
'
=
nlb I n03 + 03b) + I3y 2
(A14)
(A15)
(A16)
(A17)
All terms are defined as in the one site model with the additional
subscripts 1 for primary and 2 for secondary interaction. The six coupled
nonlinear partial differential equations were solved numerically.
The sugar D-Mannose when in solution, exists in two different optical
conformations. The ,B conformation comprises 32.6% of the population
(46) and has a dissociation constant which is an order of magnitude
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klxAgo#1 = k-
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FIGURE 6 Effect of a racemic mixture of Mannose binding sites on Con
A recovery curve. The shaded region represents the area in which
recovery is not significantly different from that of diffusion alone and
binding parameters cannot be obtained. Parameters used for this
simulation are: Da, = 1,849, Da2 = 894, ,B = 16.85, ,2 = 0.96, a, =
0.011, a2 = 0.002, y = 3. Secondary binding to , Mannose does not
alter the recovery curve for Con A's binding to Mannose in product
M6400.
higher than that of a D-Mannose (17). As seen in Fig. 6, if the
immobilized Mannose binding sites in product M6400 are in a racemic
mixture, the effect of secondary binding to the ,B Mannose is negligible
when compared with one site binding to the a sugar when Ago in the one
site model is reduced 32.6%.
APPENDIX B
Window averaging technique
The window averaging technique is analogous to the photomultiplier/
aperture technique used in reference 47. The use of video digitization,
however, allows for a more sensitive placement of the monitoring region
than an aperture. Development of the window averaging technique
proceeds along a similar line as the analysis of the no convection
assumption. The window size is first optimized using a nonbinding
model. Again the nonbinding case represents a worst case scenario
because convection without binding yields the largest flux of mobile
macromolecule and the largest associated error. Integration of the
numerical solutions obtained for the GPD method then provides
sensitivity and feasibility analysis for the window averaging technique.
-z 0
FIGURE 8 Dimensionless average concentration as a function of dimen-
sionless time and Peclet number for dimensionless region size u = 0.5.
Negligible error is incurred by neglecting convection for physiologically
realistic Peclet numbers.
The total fluorescence intensity as a function of space and time
following a gaussian photobleach (no binding) is (12):
C(X, Y, t) = CTU - (CTU
CTB) |exD)2 P R2+ ]| ( 1)(8Dt2\ D
where terms are defined as in the GPD development. The DT IRIS
acquisition board allows for only rectangular monitoring regions so this
analysis integrates over a square window (Fig. 7). If one wishes to use a
circular aperture, one integrates in cylindrical coordinates and will
obtain a simpler mathematical expression.
The average intensity in a square window of area 4Z2 is:
I fz rzCAVg =-- 4z2ZJ Cdxdy. (B2)
Performing this integration and making the equation dimensionless
0Avg
0 y
-z
0.3
IT
FIGURE 9 Dimensionless average concentration as a function of dimen-
sionless time and region size. As the region size increases, recovery
occurs over a smaller range of dimensionless concentration, decreasing
the system's resolution.
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FIGURE 7 The fluorescence intensity is integrated over a rectangular
region to obtain the average intensity in this region.
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FIGURE 10 Sensitivity and feasibility graphs for the window averaging
technique. The shaded region represents the area in which recovery is
not significantly different from that of diffusion alone and binding
parameters cannot be obtained. Simulations were run with u = 0.5 and
the same parameters as used in Figs. 1 and 3, respectively. Conclusions
are analogous.
yields:
CAvg.10.0- CT4 u\ 08091.
0Avg = =1 7- 1rf , 0(B3)
CTU - CTB 4U ( T (B3)
Vz
u=R'
~~~~(B4)
o~~~~~~~
u being the dimensionless size of the window.
In the presence of convection, the x and y terms in Eq. Bi must be
replaced by x + vxt and y + vyt, respectively, where VX and vy are the
convective velocities in the x andy directions. The dimensionless average
concentration as a function of dimensionless time, region size, and Peclet
number becomes:
OAv =1 - 162[rf(; + iP + ef (u -v"rPex)]
X[erf( >+2,eY) + erf (u-VirPB5)
The window averaging technique presents an interesting optimization
problem. One wishes to use a large window size so that the system is
robust and the convective velocity field does not "push" the bleached
spot out of the monitoring region (Fig. 8). However, one wishes to use a
small enough monitoring region to have recovery over a large range of
dimensionless concentration (Fig. 9), increasing the system's resolution.
The window size used in the simulations presented here was arbitrarily
chosen as the smallest window size which would have an error due to the
neglection of convection of <2% for Pe = 1. The average intensity in
binding simulations was calculated by integrating the numerical solu-
tions to Eq. 12-15. Fig. 10, a and b show sensitivity and in vivo
feasibility graphs analogous to Figs. 1 and 3.
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